Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrolysin for Delirium in Critically Ill Patients
NCT06677502Enrolling by invitation
- Sponsor
- Medical University of Lublin
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Modality
- Native Peptides
- Countries
- 1
01
Overview
Randomised trial of cerebrolysin in delirium (2 arms), sponsored by Medical University of Lublin. Primary endpoints: Confusion Assessment Method for the Intensive Care Unit at 7 days and Intensive Care Delirium Screening Checklist at 7 days. Started Jan 2024; status: enrolling by invitation.
02
Drugs
cerebrolysin
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06677502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06677502.